10-Q Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001558370-18-008650`
Period End Date	20180930
Filing Date	20181106
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	knsa-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 43 Income Statement 40 Cash Flow Statement 44 Stockholders Equity 15

Balance Sheet 43 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$45.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.66M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$105.00K	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$268.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.44M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$341.53M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$125.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$25.00K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$238.00K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$1.17M	USD	Point-in-time
Advanced clinical payments	`PrepaidExpenseNoncurrent`	$1.83M	USD	Point-in-time
Total assets	`Assets`	$47.49M	USD	Point-in-time
Total assets	`Assets`	$347.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.67M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.21M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.02M	USD	Point-in-time
Deferred rent	`AccruedRentNoncurrent`	$167.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$17.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$28.19M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred shares (Series A, B and C), $0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $0 and $120,000 as of September 30, 2018 and December 31, 2017, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$470.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.29M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-55.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-91.00M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$318.91M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$47.49M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$347.10M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$50.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$20.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$26.43M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.26M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$16.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$64.03M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$32.69M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$26.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-32.69M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-16.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-64.03M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-26.16M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$396.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.99M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.62M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$169.00K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.08M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.54M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.29M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.03M	USD	3 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-51.00K	USD	1 Quarter
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-131.00K	USD	1 Quarter
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-386.00K	USD	3 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-121.00K	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-32.17M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-16.03M	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-19.21	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.25	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.62	USD	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.18M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.94M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.68M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.17M	shares	3 Qtrs

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-32.17M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-60.65M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$12.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$20.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$32.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$8.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$3.12M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$550.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-66.00K	USD	3 Qtrs
Non-cash rent expense	`NonCashRentExpense`	$258.00K	USD	3 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$670.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-168.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-935.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.41M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.03M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.98M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.01M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$323.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.45M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.37M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.84M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.27M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00K	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$292.58M	USD	3 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$25.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-65.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-268.86M	USD	3 Qtrs
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	$3.65M	USD	3 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$76.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.87M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$346.44M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$12.97M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$24.21M	USD	3 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.04M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.04M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$345.00K	USD	3 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$11.00K	USD	3 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.06M	USD	3 Qtrs

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the end of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time
Conversion of convertible preferred shares into common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$310.59M	USD	3 Qtrs
Issuance of Class A common shares upon completion of initial public offering, net of underwriting discounts and commissions and offering costs	`StockIssuedDuringPeriodValueNewIssues`	$155.54M	USD	3 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$76.00K	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.12M	USD	3 Qtrs
Unrealized gain (loss) on short term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-55.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.17M	USD	3 Qtrs
Balance at the end of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.